(Q39043196)

English

Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice.

scientific article published on 7 March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jayakumar Narayanan Vadakekolathu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Shraddha S Rane

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Alan G. Pockley

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Stephanie Mcardle

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Jaimy M S Saif

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Danielle McDonald

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Morgan Mathieu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Lindy Durrant

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Rachael Metheringham

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Robert C Rees

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

0 references

publication date

7 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

44

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

994-1004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Perspectives on immunotherapy in prostate cancer and solid tumors: where is the future?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Tissue-specificity of prostate specific antigens: comparative analysis of transcript levels in prostate and non-prostatic tissues

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Using monoclonal antibodies to stimulate antitumor cellular immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Prostatic acid phosphatase as a target molecule in specific immunotherapy for patients with nonprostate adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

A phase I study of a DNA vaccine targeting prostatic Acid phosphatase in patients with stage D0 prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Identification of HLA-DRB1*1501-restricted T-cell epitopes from prostate-specific antigen.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

HLA anchor optimization of the melan-A-HLA-A2 epitope within a long peptide is required for efficient cross-priming of human tumor-reactive T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Cancer immunotherapy: synthetic and natural peptides in the balance.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Antibodies designed as effective cancer vaccines.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

High avidity cytotoxic T lymphocytes can be selected into the memory pool but they are exquisitely sensitive to functional impairment

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

High-avidity T cells are preferentially tolerized in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Toward integrative cancer immunotherapy: targeting the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Cancer incidence and mortality in Europe, 2004

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

21 January 2018

Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

7 January 2021

based on heuristic

inferred from DOI database lookup

A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA vaccination with T-cell epitopes encoded within Ab molecules induces high-avidity anti-tumor CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

7 January 2021

based on heuristic

inferred from DOI database lookup

In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343863

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJI.201343863

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338683%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39043196&oldid=1450591019"